HAB Healthcare & Investigation Limited represents a entity in the local healthcare landscape. Launched in 1949, it has established a strong name for producing high-quality common drugs and actively invests in continuous development to enhance patient health. Their offering features multiple therapeutic segments, demonstrating their focus to address